EXAS vs TASK
EXACT Sciences Corporation (EXAS) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
EXAS currently screens at market cap $20.03B. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the EXAS and TASK stock pages for the full models.
Not investment advice.